Celyad Oncology SA · EURONEXT:CYAD
Celyad Oncology SA — Fact Sheet (June 2022)
1 slide from Celyad Oncology SA's fact sheet, June 2022
Slide 1: Allogeneic Non Gene-Edited shRNA Platform
Allogeneic Non Gene-Edited shRNA Platform The ability to control gene expression and optimize function of CAR T cells is essential in order to expand application of CAR T therapies to a wider range of cancers Short hairpin RNA (shRNA) is a small piece of RNA that can decrease gene expression, effect